Avicanna Stock

Avicanna Equity 2024

Avicanna Equity

-112,500 CAD

Ticker

AVCN.TO

ISIN

CA05368K1003

WKN

A2PN04

In 2024, Avicanna's equity was -112,500 CAD, a -70.39% increase from the -380,000 CAD equity in the previous year.

Avicanna Aktienanalyse

What does Avicanna do?

Avicanna Inc is a Canadian biopharmaceutical company specializing in the research, development, and manufacturing of medical marijuana products. The company was founded in 2016 by its president and CEO Aras Azadian, who has extensive experience in the pharmaceutical and biotechnology industry. The company is based in Toronto, Canada and also operates in Colombia and Switzerland. Avicanna has several subsidiaries, including Santa Marta Golden Hemp, which operates its cultivation business in Colombia. Avicanna's business model is focused on producing medical marijuana products that have better efficacy and tolerability than conventional products. The company uses a specialized process called PhytoVista™ to isolate and extract the active ingredients in plant extracts. Avicanna operates in various sectors, including the manufacturing and marketing of medical marijuana products, research and development of effective medical treatments, and collaboration with healthcare facilities and government agencies in marijuana regulation. The company offers a variety of products, including different types of hemp oil, CBD products, and pharmaceutical products such as Rho PhytoTM and Pura EarthTM. These products all share the common approach of providing patients with better, more effective, and tolerable treatment options. Rho PhytoTM is a patented medical marijuana product by Avicanna, derived from a specific cannabis strain called ACMPR. This product is approved in Canada and available as an oral solution and syringe. Rho PhytoTM is specifically tailored to meet the needs of patients with neurodegenerative diseases and has proven to be effective. Pura EarthTM is a herbal remedy derived from the medical marijuana plant and is intended to be used as an alternative medicine for pain and inflammation. In addition to manufacturing medical marijuana products, the company also conducts intensive research and development to develop medications based on synthetic cannabinoids. These substances have the potential to help patients with various conditions such as multiple sclerosis, epilepsy, and tumor diseases. Avicanna also has partnerships with various healthcare facilities and government agencies to advance the regulation of medical marijuana and ensure the safety and efficacy of these products. In summary, Avicanna is an innovative biopharmaceutical company specializing in the manufacturing and marketing of medical marijuana products. The company serves various areas within the marijuana industry, including the production of medical products, research and development, and regulation of marijuana products. With an extensive product range and a strong research and development department, Avicanna is well positioned to continue growing and developing more innovative products in the coming years. Avicanna ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Avicanna's Equity

Avicanna's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Avicanna's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Avicanna's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Avicanna's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Avicanna’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Avicanna stock

What is the equity of Avicanna this year?

Avicanna has equity of -112,500 CAD this year.

What was the equity of Avicanna compared to the previous year?

The equity of Avicanna has increased/decreased by -70.39% decreased compared to the previous year.

What impact does a high equity have on investors of Avicanna?

A high equity is advantageous for investors of Avicanna as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Avicanna?

A low equity can be a risk for investors of Avicanna, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Avicanna affect the company?

An increase in equity of Avicanna can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Avicanna affect the company?

A reduction in equity of Avicanna can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Avicanna?

Some factors that can affect the equity of Avicanna include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Avicanna so important for investors?

The equity of Avicanna is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Avicanna take to change the equity?

To change equity, Avicanna can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Avicanna pay?

Over the past 12 months, Avicanna paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avicanna is expected to pay a dividend of 0 CAD.

What is the dividend yield of Avicanna?

The current dividend yield of Avicanna is .

When does Avicanna pay dividends?

Avicanna pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avicanna?

Avicanna paid dividends every year for the past 0 years.

What is the dividend of Avicanna?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avicanna located?

Avicanna is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avicanna kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avicanna from 7/17/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 7/17/2024.

When did Avicanna pay the last dividend?

The last dividend was paid out on 7/17/2024.

What was the dividend of Avicanna in the year 2023?

In the year 2023, Avicanna distributed 0 CAD as dividends.

In which currency does Avicanna pay out the dividend?

The dividends of Avicanna are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Avicanna stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Avicanna

Our stock analysis for Avicanna Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avicanna Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.